Skip to content
Star Imaging and Path Lab logo

Star Imaging and Path Lab

544482 BSE
₹68.90

Close ·

View as Markdown
MCP
Close 4 Nov 2026 ₹68.90 −70.10 −50.4% 1Y
Start ₹139.00

Key Fundamentals

SMEHealthcare ServicesHealthcare

Price-based figures at the close · TTM

ROCE
26.10%
Debt to Equity
0.18
EPS (TTM)
—
Book Value
₹66.65
Market Cap
—
P/E (TTM)
—
P/B
1.03
ROE
23.60%
Dividend Yield
0.00%
EBITDA
₹34.20 Cr
52W High
₹152.00
52W Low
₹46.00

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

60 Good

Data confidence 81/100

Category scores

Quality
81
Strong
Returns, margins, earnings quality 22% weight
Valuation
68
Strong
Cheap vs sector & own history 24% weight
Growth
44
Weak
Sales & profit trajectory 9% weight
Financial Health
61
Good
Solvency, leverage, coverage 9% weight
Momentum
29
Poor
Trend strength, vol-adjusted 12% weight
Ownership
48
Average
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

3
  • Company has reduced debt.
  • Stock is trading at 1.17 times its book value
  • Company has a good return on equity (ROE) track record: 3 Years ROE 32.1%

Weaknesses

3
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has high debtors of 212 days.
  • Working capital days have increased from 97.5 days to 146 days

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallStrong Bearish1270
OscillatorsBearish270
Moving AveragesStrong Bearish1000

Key readings

RSI (14)
36.06
Neutral
MACD (12,26,9)
−2.37
Bearish
SMA (50)
78.73
Bearish
SMA (200)
78.49
Bearish

As of

Growth Rate

From the financial statements below. 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025.

Revenue

Revenue growth by window
3Y+14.03%
1Y+4.88%

Net profit

Net profit growth by window
3Y+166.84%
1Y+18.75%

Operating cash flow

Operating cash flow growth by window
3Y+66.31%
1YTurned positive

Operating margin· change in pp

Operating margin growth by window
3Y+28.03 pp
1Y+3.00 pp

Trailing twelve months: Results are not reported for each of the last eight quarters, so there is no trailing-twelve-month figure.

Revenue by year

Revenue by year, ₹ crore
Mar 2022₹69.00 Cr
Mar 2023₹58.00 Cr
Mar 2024₹79.00 Cr
Mar 2025₹82.00 Cr
Mar 2026₹86.00 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2022₹6.00 Cr
Mar 2023₹1.00 Cr
Mar 2024₹12.00 Cr
Mar 2025₹16.00 Cr
Mar 2026₹19.00 Cr

Half-yearly Results

₹ Cr
544482 half-yearly results, ₹ crore
Particulars Sep 2024Mar 2025Sep 2025Mar 2026
Sales
43
41
45
43
Expenses
31
24
28
27
Operating Profit
12
17
17
16
OPM %
27%
41%
38%
37%
Other Income
0
0
0
1
Interest
1
1
1
1
Depreciation
2
3
3
3
PBT
8
13
14
13
Tax %
25%
26%
26%
28%
Net Profit
6
10
10
9
EPS (₹)
4.6
7.19
5.77
5.3

Profit & Loss

₹ Cr
544482 profit and loss, annual, ₹ crore
Particulars Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales
69
58
79
82
86
Expenses
54
52
55
53
53
Operating Profit
15
6
23
29
33
OPM %
21%
10%
30%
35%
39%
Other Income
0
0
1
0
1
Interest
2
2
3
3
2
Depreciation
4
3
5
5
6
PBT
9
1
16
21
26
Tax %
33%
35%
23%
26%
27%
Net Profit
6
1
12
16
19
EPS (₹)
4.66
0.43
9.2
11.8
11.07
Div. Payout %
0%
0%
0%
0%
0%

Balance Sheet

₹ Cr
544482 balance sheet, annual, ₹ crore
Particulars Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
2
2
2
14
17
Reserves
17
17
30
34
99
Borrowings
30
27
31
33
21
Other Liabilities
10
16
20
18
17
Total Liabilities
58
61
82
98
154
Fixed Assets
15
19
22
21
25
CWIP
0
0
0
0
0
Investments
0
0
0
0
0
Other Assets
43
42
60
77
128
Total Assets
58
61
82
98
154

Cash Flow

₹ Cr
544482 cash flow, annual, ₹ crore
Particulars Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
14
5
18
−3
23
Investing
−4
−7
−7
−7
−13
Financing
−7
−5
2
0
36
Net Cash Flow
3
−7
13
−10
46
Free Cash Flow
10
−2
11
−7
13
CFO/EBITDA
119
95
95
10
91

Ratios

544482 financial ratios, annual
Particulars Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
85
110
152
226
212
Cash Conversion Cycle
85
110
152
226
212
Working Capital Days
6
−13
23
124
146
ROCE %
—
6%
34%
34%
26%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Star Imaging and Path Lab insights

56 extracted metrics across FY22–FY26.

Shareholding Pattern

As of Sep 2026

  • Promoters 71.92%
  • Public 17.18%
  • DIIs 6.17%
  • Others 4.27%
  • Government 0.41%
  • FIIs 0.06%

No promoter shares pledged as of 14 Oct 2026

Change vs previous quarter

Documents

Frequently Asked Questions about Star Imaging and Path Lab

What does Star Imaging and Path Lab Ltd do?
Incorporated in 2004, Star Imaging and Path Lab Limited is a healthcare company providing diagnostic services across a wide range of medical tests.
Where is Star Imaging and Path Lab Ltd (STARIMAGIN) listed?
Star Imaging and Path Lab Ltd trades under code 544482 on the BSE.
Which sector does Star Imaging and Path Lab Ltd belong to?
Star Imaging and Path Lab Ltd is classified under the Healthcare Services sector, in the Healthcare Service Provider industry.
What is the 52-week high and low of Star Imaging and Path Lab Ltd?
Over the last 52 weeks Star Imaging and Path Lab Ltd has traded between ₹46 and ₹152 as of 4 Nov 2026.
What is the Return on Equity (ROE) of Star Imaging and Path Lab Ltd?
Star Imaging and Path Lab Ltd reported a return on equity of 23.60%. Its debt-to-equity ratio is 0.18.

Company Information

Incorporated in 2004, Star Imaging and Path Lab Limited is a healthcare company providing diagnostic services across a wide range of medical tests.

Website starimaging.in
Listed 18 Aug 2025
Face Value ₹10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/544482.md for Star Imaging and Path Lab Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Hospital & Healthcare Services stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month